Leucid Bio

Private

LondonHealthcare & Life Scienceshttps://www.leucid.com/

Last Round

Series A

Extension

Feb 1, 2025

Total Funding Raised

$25.35M

Company Overview

Leucid Bio is a biotechnology company that develops next-generation Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T therapycell therapysolid tumor oncologybiotechnologycancer immunotherapytumor microenvironmentdrug discoveryclinical-stage biotechnext-gen CAR-Tbiopharma R&Dclinical trialsprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leucid Bio Comparables

Compare Leucid Bio with similar companies based on industry and business-model similarity.

Leucid Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Inceptor Bio	88%
Innovative Cellular Therapeutics	86%
AffyImmune Therapeutics	84%

View all Comparables

Leucid Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Feb 1, 2025
Series A	Oct 21, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Filippo Petti

Chief Executive Officer

Executive Team

Leucid Bio Investors

Notable investors and investment history

Leucid Bio investors
Investor	Rounds
Epidarex Capital	Series A Extension, Series A
2invest AG	Series A, Series A Extension
Vulpes Investment Management	Series A
Sofinnova Partners	Series A

View all Investors

Leucid Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Leucid Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Leucid Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range23

Year Founded2014

Last FundingFeb 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.